Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Stem Cell Research is Scopus-indexed (Q3, CiteScore 1.2), WoS SCIE, DOAJ. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 1873-5061Verify ISSN ↗1876-7753Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 339 / 669 | 49th | Q3 |
| Developmental Biology | 73 / 78 | 7th | Q4 |
| Cell Biology | 270 / 289 | 6th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2007–present, best quartile Q3, CiteScore 1.2.
Stem Cell Research is Q3 in Medicine (all) (rank 339 of 669), Q4 in Developmental Biology (rank 73 of 78) and Q4 in Cell Biology (rank 270 of 289), by CiteScore 2025.
Stem Cell Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.2, which places it in quartile Q3 at the 49th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.333, quartile Q3, with an H-index of 86.
The publisher lists an article processing charge of about US$2,360 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Stem Cell Research is published by Elsevier B.V. Its print ISSN is 1873-5061 and its online ISSN is 1876-7753.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Stem Cell Research has an h-index of 97 and a 2-year mean of 0.71 citations per paper (OpenAlex). Its Scopus CiteScore is 1.2, quartile Q3. On 2-year citations it ranks #317 of 646 Scopus journals in Medicine (all).
Stem Cell Research published 246 papers in 2025; its busiest recent year was 2021 with 487. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from United States (21.3%), China (15%) and Germany (9.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 5 retracted papers are recorded (1.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.